机构：[1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.神经科系统神经外科首都医科大学宣武医院[2]Department of Neurosurgery, Affiliated Ri Zhao People's Hospital, Jining Medical College, Rizhao, Shandong 276826, China.[3]Department of Vasculocardiology, Affiliated Ri Zhao People's Hospital, Jining Medical College, Rizhao, Shandong 276826, China.[4]Experimental Diagnostic Center for Infectious Diseases, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
This work was funded by the National Natural Science
Foundation of China (No. 82373403 to Y.C.) and the Beijing
New-Star Plan of Science and Technology (China) (No.
Z201100006820148 to Y.C.).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类|2 区医学
小类|2 区生化与分子生物学2 区遗传学
最新[2025]版：
大类|2 区医学
小类|2 区生化与分子生物学2 区遗传学
第一作者：
第一作者机构：[1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.[2]Department of Neurosurgery, Affiliated Ri Zhao People's Hospital, Jining Medical College, Rizhao, Shandong 276826, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Cao Jun,Chen Si,An Ping,et al.Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme[J].Genes & Diseases.2025,12(4):101431.doi:10.1016/j.gendis.2024.101431.
APA：
Cao Jun,Chen Si,An Ping,Wang Xingqiang,Xiao Xinru...&Cheng Ye.(2025).Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme.Genes & Diseases,12,(4)
MLA：
Cao Jun,et al."Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme".Genes & Diseases 12..4(2025):101431
